SCHEMBL1423904

SCHEMBL1423904

COc1cc(-c2cc(=O)c3c(OC)c(I)c(OC)cc3o2)ccc1OCc1ccccc1.COc1cc(OC)c(-c2cc(=O)c3c(OC)c(I)c(OC)cc3o2)cc1OC.COc1cc2oc(-c3cc(OC)c(OC)c(OC)c3)cc(=O)c2c(OC)c1I.COc1ccc(-c2cc(=O)c3c(OC)c(I)c(OC)cc3o2)cc1

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ ALDH1A1 P00352 1/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ ABCB1 P08183 3/20 0.49
▸ TP53 P04637 1/20 0.49
▸ MDM2 Q00987 1/20 0.49
▸ ABCG2 Q9UNQ0 1/20 0.49
▸ FLT3 P36888 1/20 0.49
▸ ACHE P22303 2/20 0.48
▸ CYP1A1 P04798 3/20 0.47
▸ CYP1A2 P05177 3/20 0.47
▸ CYP1B1 Q16678 2/20 0.47
▸ OPRD1 P41143 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Corymbosin SCHEMBL1421623 0.90 MAOB (0.56) MEN1KMT2AALDH1A1L3MBTL1ABCB1
SCHEMBL1977048 0.88 ABCB1 (0.59) MEN1KMT2AL3MBTL1ABCB1TP53
SCHEMBL1421607 0.84 FLT3 (0.56) MEN1KMT2AALDH1A1L3MBTL1ABCB1
SCHEMBL24514601 0.82 ABCB1 (0.73) MEN1KMT2AALDH1A1L3MBTL1ABCB1
SCHEMBL24514598 0.81 ABCB1 (0.68) MEN1KMT2AALDH1A1L3MBTL1ABCB1
SCHEMBL7156543 0.80 ABCB1 (0.69) MEN1KMT2AALDH1A1L3MBTL1ABCB1
SCHEMBL1976409 0.80 CYP1A1 (0.59) MEN1KMT2AALDH1A1L3MBTL1ABCB1
SCHEMBL8062100 0.79 MEN1 (0.71) MEN1KMT2AALDH1A1L3MBTL1ABCB1
SCHEMBL24514602 0.79 CYP1A1 (0.75) MEN1KMT2AABCB1TP53MDM2
SCHEMBL21206267 0.78 ABCB1 (0.73) MEN1KMT2AALDH1A1ABCB1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2297127-A1 CHROMENONE DERIVATIVES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES AxoGlia Therapeutics S.A. (LU) 2011-03-23 — — EP disclosed
WO-2009130253-A1 CHROMENONE DERIVATIVES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES AXOGLIA THERAPEUTICS S.A. (LU) 2009-10-29 — — WO disclosed
Send feedback